• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板生成素是白细胞介素6吗?

Is thrombopoietin interleukin 6?

作者信息

Williams N

机构信息

Department of Physiology, University of Melbourne, Parkville, Victoria, Australia.

出版信息

Exp Hematol. 1991 Aug;19(7):714-8.

PMID:1893958
Abstract

Recent data concerning to ability of interleukin 6 (IL-6) to stimulate platelet production have raised the possibility that platelet production is not specifically regulated by a unique feedback mechanism, but is part of a network encompassing several hemopoietic growth factors. Hypotheses are presented about the nature of thrombopoietin, its relationship to known growth factors, especially IL-6, and the specificity of a thrombopoietic response following change in the circulating platelet mass.

摘要

最近有关白细胞介素6(IL-6)刺激血小板生成能力的数据表明,血小板生成可能并非由独特的反馈机制特异性调节,而是包含多种造血生长因子的网络的一部分。文中提出了关于血小板生成素的性质、其与已知生长因子特别是IL-6的关系,以及循环血小板量变化后血小板生成反应特异性的假说。

相似文献

1
Is thrombopoietin interleukin 6?血小板生成素是白细胞介素6吗?
Exp Hematol. 1991 Aug;19(7):714-8.
2
Stimulators of megakaryocyte development and platelet production.
Prog Growth Factor Res. 1990;2(2):81-95. doi: 10.1016/0955-2235(90)90025-f.
3
Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.血小板生成素在巨核细胞祖细胞水平的作用对于随后的前血小板生成至关重要。
Exp Hematol. 1997 Feb;25(2):169-76.
4
[The factor to take a part of platelet production step: distinction from thrombopoietin].[参与血小板生成步骤的因素:与血小板生成素的区别]
Rinsho Ketsueki. 2000 Jun;41(6):449-53.
5
Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth regulators.糖胺聚糖通过调节造血生长调节因子的活性来增强巨核细胞生成。
J Cell Physiol. 1996 Jul;168(1):97-104. doi: 10.1002/(SICI)1097-4652(199607)168:1<97::AID-JCP12>3.0.CO;2-M.
6
Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.白细胞介素-6和白细胞介素-11与血小板生成素和干细胞因子协同作用,以调节人CD41+和CD61+巨核细胞的体外扩增。
Haematologica. 2000 Jan;85(1):25-30.
7
[Thrombopoietin and the control of platelet production (author's transl)].血小板生成素与血小板生成的调控(作者译)
Nouv Rev Fr Hematol (1978). 1979;21(2):209-18.
8
Megakaryocytic regulatory factors in vivo and in vitro.体内和体外的巨核细胞调节因子
Prog Clin Biol Res. 1986;215:157-77.
9
Sequential treatment with rmIL-3 or simultaneous treatment with rmIL-3 or rhIL-11 with thrombopoietin (TPO) fails to enhance in vivo neonatal rat thrombocytopoiesis.用重组人白细胞介素-3(rmIL-3)进行序贯治疗,或用重组人白细胞介素-3(rmIL-3)或重组人白细胞介素-11(rhIL-11)与血小板生成素(TPO)同时治疗,均无法增强新生大鼠体内的血小板生成。
Exp Hematol. 1997 Aug;25(9):1005-12.
10
Failing to live up to the fanfare? A personal perspective on obstacles to the clinical development of thrombopoietic agents.辜负了大肆宣传?关于血小板生成剂临床开发障碍的个人观点。
Int J Hematol. 2001 Dec;74(4):390-6. doi: 10.1007/BF02982081.

引用本文的文献

1
PEGylated thrombopoietin mimetic, JNJ‑26366821 a novel prophylactic radiation countermeasure for acute radiation injury.聚乙二醇化血小板生成素模拟物,JNJ-26366821,一种新型的急性辐射损伤预防辐射对策。
Sci Rep. 2023 Sep 14;13(1):15211. doi: 10.1038/s41598-023-42443-0.
2
The molecular mechanisms that control thrombopoiesis.控制血小板生成的分子机制。
J Clin Invest. 2005 Dec;115(12):3339-47. doi: 10.1172/JCI26674.
3
Thrombopoietin and platelet development.血小板生成素与血小板发育
West J Med. 1996 Mar;164(3):209-11.